ESSA Pharma Inc (EPIX) News

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024 PR Newswire SOUTH SAN FRANCISCO...

ESSA Pharma to Present at the JonesHealthcare Seaside Summit

ESSA Pharma to Present at the JonesHealthcare Seaside Summit PR Newswire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, July 8, 2024 SOUTH SAN...

ESSA Pharma to Present at the Jefferies Global Healthcare Conference

ESSA Pharma to Present at the Jefferies Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, May 30, 2024...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024 PR Newswire SOUTH SAN...

Form 4 - Statement of changes in beneficial ownership of securities

ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference PR Newswire SOUTH SAN FRANCISCO, Calif. and VANCOUVER...

ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS PR Newswire SOUTH SAN FRANCISCO, USA and VANCOUVER, CANADA, March 7...

Form 8-K - Current report